Orange County child is first youth in US to take part in FDA trial of medical device to prevent epileptic seizures

Ameera Aravena, 12, is currently the first child in the U.S. to take part in the Food and Drug Administration trial.

News 12 Staff

Dec 7, 2022, 10:53 PM

Updated 496 days ago

Share:

A lifesaving medical device for adults who suffer from epileptic seizures could soon be approved for use in children.
News 12 spoke with an Orange County child who is experiencing Neuro Pace firsthand.
Ameera Aravena, 12, is currently the first child in the U.S. to take part in the Food and Drug Administration trial.
"It zaps the seizures to stop the seizures," says Dr. Steven Wolf, director of pediatric epilepsy, at Westchester Medical Center. "We use this computer chip to put electrodes right over where the seizure comes from." 
Ameera's medical team pinpointed where the seizures come from, and in went the tiny device latching onto the left side of her brain two months ago.
"With a special wand, patients can retrieve the data. It then goes up into the cloud, and from there, medical providers can see it on a computer and then analyze it.
Their goal is to be able to use the device and less medicine to help control seizures better.
The trial is ongoing, so people who may be a suitable candidate should contact a medical professional or neurologist.   


More from News 12